<DOC>
	<DOCNO>NCT00818545</DOCNO>
	<brief_summary>The stratum corneum ( SC ) superficial layer epidermis situate interface body outside environment . Its strategic position confers crucial role protection aggression . After disruption , kinetic cutaneous barrier slow elderly comparatively young subject . The purpose study investigate , characterize molecular event , effectiveness ER4017 ( Hydroxypropyltetrahydropyrantriol ) restore kinetic barrier function acute disruption stratum corneum ederly subject . 10 male volunteer age 60 75 year randomize receive topical application ER4017 versus placebo skin inner forearm twice day 3 month . After sequential selloptape strip , epidermal sample treat control skin remove local anesthesia , use dermatome . Differential gene expression analysis perform use micro array technique quantitative RT-PCR . treatment , randomize location , double blind , placebo control , internal control subject , prospective study .</brief_summary>
	<brief_title>Transcriptomic Study ER 4017 Topical Application Elderly Subject</brief_title>
	<detailed_description>Structural modification superficial dermis age process associate alteration GAG- PG profile appear impact quality dermal epidermal junction ( DEJ ) . Previous biological clinical evaluation ER4017 , C-glycoside biomimetic xylose , show capacity stimulate GAG- PG synthesis improve morphogenesis whole DEJ . The aim study investigate gene expression human epidermis treat ER4017 follow sequential sellotape strip 3 month ER4017 topical application . For purpose , modulation gene expression determine use cDNA microarray technology . Stratum corneum disruption perform follow 3 month topical application skin inner forearm . All experiment perform 10 elderly healthy men . Volunteers clinically biophysically evaluate baseline monthly interval 3 month respectively .</detailed_description>
	<criteria>Phototype I III Healthy skin study skin area Subject freely give informed write consent . Cooperative subject , aware necessity attend schedule appointment study . Negative serology HIV , hepatitis B hepatitis C No past present history allergy link either one ingredient study cosmetic cream test xyloca√Øne ( anesthesia ) . Cutaneous disease previous malignant cutaneous lesion test zone . Any treatment able act blood coagulation homeostasis .</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>age</keyword>
	<keyword>barrier function</keyword>
	<keyword>transcriptomic</keyword>
</DOC>